Dunyagoz Eye Hospital Istanbul Etiler
Op. Dr. Alasgar Asgarli, MD, is an ophthalmologist. He focuses on cataract and refractive surgery, glaucoma diagnosis and treatment, medical retinal diseases, and pediatric eye care. He performs oculoplastic eyelid surgery and ocular trauma surgery. His skills include intravitreal injections, pterygium excision, and neuro-ophthalmology. He also has experience with advanced intraocular lens fixation, including scleral fixation and the Yamane technique.
Achievements and accreditations: Active member of the Turkish Ophthalmological Association (TOD). Presenter at the TOD 59th National Congress. Attended the TOD 58th National Congress. Completed the TOD Fundus Fluorescein Angiography Course (2024). Published “Comparison of the Effects of Hydrophobic and Hydrophilic Acrylic Intraocular Lenses on Lenticular Astigmatism” (DOI: 10.37844/TJ-CEO.2025.20.37). Holds certification in Botox and dermal fillers.
Dr. Ali Riza Cenk Celebi is an ophthalmologist at İstinye University Liv Hospital Topkapı. He completed a glaucoma fellowship at Harvard Medical School. Dr. Celebi authored over 50 international articles and 15 books. He ranked 11th out of all medical graduates in Turkey's specialty exam.
Dr. Yucel Ozturk is an ophthalmologist at Dunyagoz Eye Hospital Istanbul Atakoy. He has performed over 30,000 surgical cases. Dr. Ozturk treats complex eye conditions like optic nerve atrophy and cataracts. He works at a JCI-accredited facility that treats 50,000 patients annually.
Dr. Mehmet Orçun Akdemir is an ophthalmologist at Veni Vidi Eye Clinics in Istanbul. He specializes in cornea treatments, including keratoconus management and complex keratoplasty procedures. He is a member of the Turkish Ophthalmology Association. Dr. Akdemir works at an ISO 9001 certified center that treats 50,000 patients annually.
Optic nerve atrophy is generally irreversible because dead nerve fibers cannot regenerate. Treatment focus is on stopping further vision loss by addressing underlying causes. Specialized clinics in Turkey use neuro-ophthalmology assessments and advanced imaging to stabilize remaining vision and prevent additional damage.
Bookimed Expert Insight: Turkish eye hospitals often handle much higher patient volumes than European centers. Dunyagoz Eye Hospital treats 66,000 patients every year. This massive caseload means specialists see rare neuro-ophthalmic disorders daily. They can often diagnose the root cause faster which is vital for saving remaining vision.
Patient Consensus: Patients note that controlling inflammation or pressure sometimes brings slight vision improvements. However, they emphasize that early diagnosis is the only way to effectively stop the atrophy from progressing.
Turkey offers advanced optic nerve atrophy care within JCI-accredited facilities. Patients access neuro-ophthalmology evaluations, stem cell therapies, and specialized surgeries. Leading centers in Istanbul integrate diagnostic imaging like OCT and MRI to determine the underlying cause before starting treatment.
Bookimed Expert Insight: Patient volume indicates that eye centers like Dunyagoz Etiler treat 66,000+ patients annually. This high frequency allows surgeons to specialize in rare neuro-ophthalmology cases that general clinics see less often. Choosing a clinic with high surgical turnover often ensures better access to the newest intraocular lens techniques or laser equipment.
Patient Consensus: Patients note it is important to bring recent OCT scans and MRI reports for independent review. They recommend focusing on preserving existing vision rather than expecting a full cure, as recovery typically requires significant patience.
Treatments for optic nerve atrophy focus on stabilizing vision rather than regeneration. Common side effects include immune suppression from corticosteroids or localized inflammation from stem cell injections. Physical risks like bleeding or infection relate to surgical procedures. Success depends on managing the underlying cause effectively.
Bookimed Expert Insight: Turkish eye hospitals like Dunyagoz and Veni Vidi perform 30,000+ surgeries annually. This high volume often leads to better risk management for complex cases. Many patients choose these centers because they offer advanced diagnostics like 512-slice CT. High-tech imaging helps doctors identify the exact cause and avoid unnecessary procedures.
Patient Consensus: Patients note that initial soreness at the injection site is common after cell-based therapies. Many emphasize that the primary challenge is managing expectations, as treatments often aim only to stop further vision loss.
Stem cell therapy for optic nerve atrophy shows effectiveness in up to 83% of cases. Turkish specialists utilize autologous bone marrow or umbilical cord cells to stimulate existing nerve tissues. This experimental approach aims to improve light perception and reduce visual strain rather than fully restoring total vision.
Bookimed Expert Insight: Patient volume is a major indicator of clinical expertise in Turkey. Dunyagoz Eye Hospital Istanbul Etiler treats 66,000 patients annually. High-volume centers often provide access to specialized surgeons like Dr. Yucel Ozturk. He has performed over 30,000 surgical cases. Choosing such experienced specialists can be more critical for rare conditions than any specific technology.
Patient Consensus: Patients note that initial results are subtle and require significant patience after the procedure. Many emphasize checking exactly which cell types are used to avoid being misled by vague marketing promises.
International patients in Turkey navigate a structured process including remote record review, diagnostic confirmation, and coordinated logistics. Facilities like Anadolu Medical Center and Memorial Şişli Hospital provide JCI-accredited care. The journey typically begins with submitting scans for specialist evaluation before patients travel for specialized treatments.
Bookimed Expert Insight: Data shows Turkey dominates as the top destination for international medical requests, serving over 32,000 patients annually. Large networks like Dunyagoz Eye Hospital manage over 60,000 patients each year through highly specialized sub-units. This high volume allows clinics to maintain 24/7 operations and offer niche expertise in complex neuro-ophthalmology cases.
Patient Consensus: Patients note it is essential to bring both digital and hard copies of all eye imaging. Many emphasize the need to schedule extra days for repeat testing and detailed specialist consultations.
Early intervention is vital for optic nerve atrophy treatment in Turkey. Specialists emphasize treating the underlying cause while residual vision remains. Success depends on addressing active issues like inflammation, pressure, or vascular deficits. Once atrophy is complete, restoring lost vision becomes significantly more difficult.
Bookimed Expert Insight: Data shows high-volume centers like Dunyagoz Eye Hospital treat 66,000 patients annually. Their experience suggests that stability is the primary goal for chronic cases. Patients should look for surgeons like Dr. Yucel Ozturk, who has performed 30,000 surgeries. Experts with this volume can better identify which cases actually benefit from intervention.
Patient Consensus: Patients note that results from regenerative treatments may take more than 15 days to appear. They emphasize that managing expectations for recovery is essential when dealing with long-term nerve damage.
Specialists in Turkey treat optic nerve atrophy by targeting underlying causes. These include glaucoma and inflammation. The aim is to prevent further vision loss. Centres in Istanbul utilise Joint Commission International (JCI) accredited facilities for neuro-ophthalmology diagnostics. They also offer stem cell therapies aimed at nerve stabilisation.
Bookimed Expert Insight: Istanbul clinics like Dunyagoz Eye Hospital manage over 60,000 eye cases annually. This high patient volume allows their neuro-ophthalmologists to gain extensive experience. Dr Mehmet Orçun Akdemir, for example, specialises in rare atrophy causes. Patients should prioritise clinics with both JCI accreditation and a dedicated neurology department. Such departments handle complex cases.
Patient Consensus: Patients note that medical teams take time to explain potential side effects. This applies to treatments like stem cell therapy. They caution that changes take time to appear. However, they appreciate the professional support during their stay in Turkey.
Stem cell therapy in Turkey is an experimental regenerative approach. It is not a definitive cure for optic nerve atrophy. Clinics often use umbilical cord cells to stabilise vision or improve functionality. Turkish centres report encouraging functional gains, though permanent nerve regeneration remains a clinical challenge.
Bookimed Expert Insight: Many people view stem cell therapy as a standalone solution. However, leading Turkish clinics often pair it with diagnostics like AI-supported 3 Tesla MRI. At hospitals like Memorial Göztepe, these scans help specialists map nerve damage precisely before treatment. This approach lets doctors confirm a patient's suitability for experimental injections.
Patient Consensus: Patients note that umbilical cord treatments require significant patience. Improvements are rarely immediate, and injection sites may remain tender. Those visiting Istanbul clinics emphasise the importance of clear communication. Talking with the surgical team helps manage expectations about long-term vision stabilisations.
Turkish clinics report success rates between 75% and 85% for improving vision. These results come from regenerative therapies for optic nerve atrophy. Leading JCI-accredited centres in Istanbul use stem cell protocols to stabilise vision. Most patients notice improvements within six months of treatment.
Bookimed Expert Insight: Success in Turkey often involves a multidisciplinary approach rather than just ophthalmology. Clinics like Memorial Sisli Hospital combine neurology and ophthalmology to address the root cause. This is vital because atrophy is often a secondary symptom of wider neurological issues.
Patient Consensus: Patients in Turkey report that results take months to appear. However, medical teams provide clear guidance on post-treatment restrictions. They note that hospital facilities are comprehensive. But patience is required during the recovery phase.
Treatment for optic nerve atrophy in Turkey typically requires a 1 to 2-week stay. Stem cell injections or bionic eye surgeries take only hours. However, patients usually stay 2 to 5 days for monitoring. Biological recovery follows a slower timeline. Improvements generally appear after 6 to 12 months.
Bookimed Expert Insight: Turkish eye centres like Dunyagoz often schedule multiple doses over a single week. For example, Dunyagoz serves 66,000 patients annually. This condensed timeline helps international patients reduce hotel costs. Major centres like Memorial Şişli maintain JCI accreditation. This supports high safety standards for complex neurological eye cases.
Patient Consensus: Patients at Memorial Şişli note the physical procedure feels quick. They emphasise that patience is essential. It is normal to feel some site soreness. No immediate vision changes are expected in the first fortnight. Many focus on long-term lifestyle changes to support the healing process.
Turkey is a leading destination for optic nerve atrophy treatment. This is because it has many internationally accredited eye hospitals and neuro-ophthalmology specialists. Leading centres in Istanbul use diagnostics and regenerative protocols. These include limbal stem cell transplantation to manage complex nerve damage.
Bookimed Expert Insight: Turkish ophthalmology leads the region. Specialists like Dr Yucel Ozturk have performed 30,000+ surgical cases. This high volume lets Istanbul surgeons refine techniques for rare neuro-ophthalmological disorders. Australian doctors may see these less frequently.
Patient Consensus: Patients note that surgeons and medical teams explain procedures clearly. This puts them at ease. The experience in Turkey often includes comprehensive support. Clinicians advise that improvements after stem cell treatments require significant patience.
Candidates for optic nerve atrophy treatment in Turkey typically have stable vision loss. This vision loss is usually caused by glaucoma, trauma, or ischaemia. Turkish specialists offer diagnostics and neuroprotective therapies for those with residual nerve function. JCI-accredited facilities require confirmed results from MRI and optical coherence tomography.
Bookimed Expert Insight: Turkey serves over 36,000 international eye patients yearly through major networks like Dunyagoz. These networks treat 62,000+ people annually. Experienced surgeons, such as Dr Yucel Ozturk with 30,000+ operations, specialise in complex cases. This high volume allows clinics to maintain sub-specialised departments for neuro-ophthalmology. Single hospitals often lack these departments.
Patient Consensus: Patients note the importance of consulting a neuro-ophthalmologist. This specialist can confirm the exact cause of atrophy before travel. Those undergoing specialist therapies in Turkey emphasise that patience is necessary. Results often take weeks to appear.